Penile Enhancement Clinical Trial
Official title:
A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement
The investigators aimed to confirm the efficacy and safety of transdermal penis enlargement
for 24 weeks after CMDHA0101 injection in subjects who wanted penile enlargement in male
patients with small-penis syndrome *.
*Small-penis syndrome is the anxiety of thinking one's penis is too small - even though it
isn't.
This study was designed as a 24-week, randomized, blinded, active control trial.
If a subject signing a clinical trial agreement and satisfying the selection / exclusion
criteria is enrolled in this clinical trial, he / she will receive the medical device for
clinical testing at the baseline time, return to his / her home after the training . At 4
weeks, 12 weeks, and 24 weeks after the application of the medical device for clinical
testing at baseline, the safety, penile girth, length, and satisfaction of the subject were
evaluated. 24 weeks after application, the clinical trial sponsor (or trustee) retrieves the
data necessary for the analysis of results, such as case records, for the purpose of validity
and safety evaluation
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03512717 -
Efficacy and Safety of Potenfill for Temporary Penile Enhancement
|
N/A | |
| Completed |
NCT02833532 -
A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement
|
Phase 3 | |
| Completed |
NCT03840070 -
The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement
|
N/A | |
| Completed |
NCT04496427 -
Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
|